Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Positive efficacy profile reported for Zonagen's Vasomax

May 30, 1997

Ono reports AGE inhibitors and antioxidants

May 29, 1997

Kyoto describes ACAT/lipid peroxidation inhibitors

May 29, 1997

Merck & Co. acquires majority share of Gentili

May 28, 1997

Nissan Chem. reveals new antidiabetic agents

May 28, 1997

MP-52 to be developed worldwide by HMR

May 27, 1997

Lilly describes new agents for postmenopausal syndrome

May 26, 1997

Squalene synthase inhibitors from Takeda

May 26, 1997

Celtrix receives additional U.S. patents

May 23, 1997

Alora launched in U.S.

May 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.